Skip to main content
Fig. 2 | BMC Surgery

Fig. 2

From: Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases

Fig. 2

Comparison of recurrence-free survival (RFS) and overall survival (OS) after curative liver resection among all patients and patients with or without neoadjuvant chemotherapy (NAC) according to tumor burden score (TBS). a, Comparison of RFS in the low and high TBS groups among all patients. b, Comparison of RFS in the low and high TBS groups among patients who received NAC. c, Comparison of RFS in the low and high TBS groups among patients who did not receive NAC. d, Comparison of OS in the low and high TBS groups among all patients. e, Comparison of OS in the low and high TBS groups among patients who received NAC. f, Comparison of OS in the low and high TBS groups among patients who did not receive NAC.

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us